Poonam Manwani, MD
Rheumatology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Manwani’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A156469 · Current
Licensed to practise in California · since 2018 · expires 2027-10-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.61155350Physician And Surgeon License · since 2021 · expires 2023-10-29ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$74,851
Medicare paid this office $74,851 for 215 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 84 | $20,968 | $166 |
| Return visit (30+ min) | 105 | $20,720 | $110 |
| New patient visit (60+ min) | 73 | $14,823 | $203 |
| Short return visit (20+ min) | 79 | $9,267 | $86 |
| New patient visit (45+ min) | 22 | $2,896 | $132 |
Who their Medicare patients are
215 Original Medicare patients in 2024. Average age 76 · Women 64% · Also on Medicaid 9% · Health risk score 1.12. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 62% · Coronary heart disease 30% · Chronic kidney disease 27% · Diabetes 20% · Atrial fibrillation 20% · Cancer 18% · Depression 16% · Heart failure 10% · COPD 6%.
The office billed $266,723, Medicare allowed $99,168 and paid $74,851; for 1,902 services of 19 kinds; $4,695 of it was for drugs given in the office and $70,156 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 215 | 1,902 | 76 | 1.12 | $266,723 | $74,851 |
| 2023 | 170 | 516 | 76 | 0.93 | $200,443 | $57,143 |
| 2022 | 136 | 278 | 75 | 1.22 | $114,620 | $31,268 |
| 2021 | 43 | 94 | 71 | 0.96 | $35,232 | $11,662 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Long return visit (40+ min) | 69 | $17,438 | $149 |
| New patient visit (60+ min) | 76 | $13,496 | $178 |
| Return visit (30+ min) | 66 | $13,118 | $110 |
| Short return visit (20+ min) | 59 | $6,537 | $74 |
| New patient visit (45+ min) | 30 | $4,009 | $134 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $30 | None |
2022: 5 services
| Long return visit (40+ min) | 95 | $17,697 | $136 |
| New patient visit (60+ min) | 32 | $5,673 | $177 |
| Return visit (30+ min) | 33 | $3,655 | $91 |
| New patient visit (45+ min) | 14 | $1,975 | $141 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 20 | $592 | $26 |
2021: 3 services
| Long return visit (40+ min) | 24 | $4,816 | $146 |
| New patient visit (60+ min) | 22 | $3,861 | $176 |
| Return visit (30+ min) | 11 | $1,191 | $99 |
Medicaid work
$7,343 in 2022
Medicaid paid $7,343 for 113 billed services this clinician did in 2022, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 113 | $7,343 |
| 2022 | 113 | 1 | 24 | $7,343 |
| 2021 | 85 | 3 | 22 | $6,315 |
See the largest Medicaid services in earlier years
2021
| Long return visit (40+ min) | 43 | $2,919 |
| New patient visit (60+ min) | 24 | $2,106 |
| New patient visit (45+ min) | 18 | $1,291 |
Drugs they prescribed that Part D paid
$375,445
Pharmacies billed $375,445 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (14 of 694) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
627 generic and 67 brand-name prescriptions · $375,445 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 19 | $150,666 | $7,930 |
| Otezla | 14 | $79,907 | $5,708 |
| Colchicine | 43 | $1,893 | $44 |
| Methotrexate | 65 | $1,592 | $24 |
| Prednisone | 185 | $1,386 | $7 |
See all 11 drugs
| Humira(Cf) | 19 | $150,666 | $7,930 |
| Otezla | 14 | $79,907 | $5,708 |
| Colchicine | 43 | $1,893 | $44 |
| Methotrexate | 65 | $1,592 | $24 |
| Prednisone | 185 | $1,386 | $7 |
| Hydroxychloroquine Sulfate | 51 | $1,276 | $25 |
| Allopurinol | 79 | $583 | $7 |
| Omeprazole | 39 | $325 | $8 |
| Entecavir | 12 | $239 | $20 |
| Pantoprazole | 15 | $81 | $5 |
| Alendronate | 11 | $19 | $2 |
Year by year
| 2024 | 694 | 134 | 2% (14) | 10% | $375,445 |
| 2023 | 418 | 89 | 0% (0) | None | $104,505 |
| 2022 | 371 | 99 | None | 13% | $193,586 |
| 2021 | 189 | 63 | 0% (0) | None | $312,876 |
| 2020 | 210 | 40 | 0% (0) | None | $360,433 |
| 2019 | 118 | 39 | 0% (0) | 28% | $114,964 |
| 2018 | 60 | 22 | 0% (0) | 20% | $23,305 |
| 2017 | 36 | 23 | 0% (0) | None | $1,243 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Colchicine | 20 | $2,251 | $113 |
| Prednisone | 163 | $1,791 | $11 |
| Hydroxychloroquine Sulfate | 33 | $1,291 | $39 |
| Methotrexate | 24 | $969 | $40 |
| Allopurinol | 23 | $399 | $17 |
| Diclofenac | 16 | $385 | $24 |
| Sulfasalazine | 13 | $296 | $23 |
| Omeprazole | 19 | $212 | $11 |
| Pantoprazole | 14 | $138 | $10 |
2022: 7 drugs
| Hydroxychloroquine Sulfate | 65 | $5,082 | $78 |
| Methotrexate | 53 | $1,717 | $32 |
| Prednisone | 96 | $1,133 | $12 |
| Sulfasalazine | 18 | $398 | $22 |
| Allopurinol | 11 | $98 | $9 |
| Meloxicam | 11 | $84 | $8 |
| Folic Acid | 11 | $57 | $5 |
2021: 4 drugs
| Methotrexate | 27 | $1,422 | $53 |
| Hydroxychloroquine Sulfate | 12 | $834 | $70 |
| Prednisone | 41 | $452 | $11 |
| Sulfasalazine | 12 | $116 | $10 |
2020: 3 drugs
| Humira | 12 | $140,036 | $11,670 |
| Methotrexate | 43 | $3,454 | $80 |
| Prednisone | 14 | $406 | $29 |
2019: 1 drug
| Methotrexate | 18 | $1,452 | $81 |
Money from drug and device companies
$13 in 2024
| 2024 | 1 | 1 | None | $13 |
| 2021 | 2 | 14 | None | $310 |
| 2020 | 3 | 25 | None | $417 |
| 2019 | 3 | 5 | None | $179 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech USA | Actemra | $13 | 1 payment
|
See the published payment
| Genentech USA | Meals · 2024-11-18 | Actemra | $13 |
See earlier years (2021, 2020, 2019)
2021: $310
| Amgen | Enbrel | $293 | 13 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $17 | 1 payment
|
2020: $417
| Amgen | Enbrel | $295 | 18 payments
|
| GlaxoSmithKline | Benlysta | $61 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $61 | 3 payments
|
2019: $179
| Amgen | Enbrel | $80 | 3 payments
|
| GlaxoSmithKline | Benlysta | $65 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $35 | 1 payment
|
Professional record
- NPI
- 1609220839
- Licence
- CA A156469, WA MD61155350California A156469: Current · expires 2027-10-31Washington MD.MD.61155350: Expired
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- WA 2180669
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2016-04-13
- NPI last updated
- 2022-09-21
- NPI record certified
- 2022-09-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1802 Yakima Ave Ste 208, Tacoma, WA, 98405
This office lists an electronic records connection.